HOME › DRUGS › ASCIMINIB
ACTIVE SUBSTANCE / INN

ASCIMINIB

Brand name(s): Scemblix
EMA LISTED
AUTHORISED
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
ACTIVE SUBSTANCE
Asciminib
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ScemblixNovartis Europharm LimitedAuthorised25/08/2022Leukemia, Myelogenous, Chronic, BCR-ABL Positive

FULL INTELLIGENCE ON ASCIMINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →